Industrial Nanotech, Inc. today announced that the Company will begin full scale manufacturing and shipping of the Company?s new patented revolutionary Nansulate EPX product next month. The Company also released additional performance specifications.
Unidym, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today the first flight of an aircraft incorporating Unidym?s carbon nanotubes into its airframe for increased strength and flexibility to combat the effects of aerodynamic stress and engine vibration.
Cadence Design Systems, Inc. today announced that Time To Market, Inc., a leading ASIC design house, was able to detect hot spots and optimize yields for a complex 65-nanometer design using a holistic design-for-manufacturability flow from Cadence that includes the Cadence SoC Encounter XL system and the Cadence Litho Physical Analyzer.
Nanopoint Inc., an award-winning developer of cellTRAY Fluidics and Imaging System products, is announcing the strong network of Asian distributorships the Company is building in order to provide the best-of-the-best customer sales and service in the expanding life science markets throughout the Far East.
Under the agreement, nanoparticle film deposition technologies developed at the university will be used by Rushford Hypersonic on products in the industrial tooling and coating applications industries.
NIL Technology now adds a high-accuracy but low-cost photonic stamp in silicon to its existing product line targeted at the growing demand for photonic crystal structures necessary for future photonic devices.
A 20-member Italian delegation representing biotech and nanotech sectors, under the aegis of the Italian Trade Commission, has offered to tie-up with Indian firms in the sunrise industry for mutual benefit.
Calando Pharmaceuticals announced that the U.S. Food and Drug Administration has approved its investigational new drug application for lead anti-cancer compound, CALAA-01. The drug candidate is a targeted nanoparticle, comprised of a proprietary, non-chemically-modified siRNA against the M2 subunit of ribonucleotide reductase formulated with Calando?s proprietary RONDEL polymer delivery system.